Medications

More biosimilars marketed in Germany, Switzerland than U.S.

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

Cardiology

Outcomes for AMI improved during 1995 to 2014

(HealthDay)—Short-term mortality and readmissions improved from 1995 to 2014 for patients with acute myocardial infarction (AMI), according to a study published online March 15 in JAMA Network Open.

HIV & AIDS

Patents making new AIDS drugs expensive, MSF says

New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.

Health

Most Americans oppose soda, candy taxes

(HealthDay)—Most U.S. adults aren't sweet on the idea of soda and candy taxes, and many doubt the bigger price tags would trim the national waistline.

page 28 from 40